Cargando…

Nucleated red blood cells, critical illness survivors and postdischarge outcomes: a cohort study

BACKGROUND: Little is known about risk factors associated with out-of-hospital outcomes in survivors of critical illness. We hypothesized that the presence of nucleated red blood cells in patients who survived critical care would be associated with adverse outcomes following hospital discharge. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Purtle, Steven W., Horkan, Clare M., Moromizato, Takuhiro, Gibbons, Fiona K., Christopher, Kenneth B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479031/
https://www.ncbi.nlm.nih.gov/pubmed/28633658
http://dx.doi.org/10.1186/s13054-017-1724-z
_version_ 1783245061197135872
author Purtle, Steven W.
Horkan, Clare M.
Moromizato, Takuhiro
Gibbons, Fiona K.
Christopher, Kenneth B.
author_facet Purtle, Steven W.
Horkan, Clare M.
Moromizato, Takuhiro
Gibbons, Fiona K.
Christopher, Kenneth B.
author_sort Purtle, Steven W.
collection PubMed
description BACKGROUND: Little is known about risk factors associated with out-of-hospital outcomes in survivors of critical illness. We hypothesized that the presence of nucleated red blood cells in patients who survived critical care would be associated with adverse outcomes following hospital discharge. METHODS: We performed a two-center observational cohort study of patients treated in medical and surgical intensive care units in Boston, Massachusetts. All data were obtained from the Research Patient Data Registry at Partners HealthCare. We studied 2878 patients, age ≥ 18 years, who received critical care between 2011 and 2015 and survived hospitalization. The exposure of interest was nucleated red blood cells occurring from 2 days prior to 7 days after critical care initiation. The primary outcome was mortality in the 90 days following hospital discharge. Secondary outcome was unplanned 30-day hospital readmission. Adjusted odds ratios were estimated by multivariable logistic regression models with inclusion of covariate terms thought to plausibly interact with both nucleated red blood cells and outcome. Adjustment included age, race (white versus nonwhite), gender, Deyo–Charlson Index, patient type (medical versus surgical), sepsis and acute organ failure. RESULTS: In patients who received critical care and survived hospitalization, the absolute risk of 90-day postdischarge mortality was 5.9%, 11.7%, 15.8% and 21.9% in patients with 0/μl, 1–100/μl, 101–200/μl and more than 200/μl nucleated red blood cells respectively. Nucleated red blood cells were a robust predictor of postdischarge mortality and remained so following multivariable adjustment. The fully adjusted odds of 90-day postdischarge mortality in patients with 1–100/μl, 101–200/μl and more than 200/μl nucleated red blood cells were 1.77 (95% CI, 1.23–2.54), 2.51 (95% CI, 1.36–4.62) and 3.72 (95% CI, 2.16–6.39) respectively, relative to patients without nucleated red blood cells. Further, the presence of nucleated red blood cells is a significant predictor of the odds of unplanned 30-day hospital readmission. CONCLUSION: In critically ill patients who survive hospitalization, the presence of nucleated red blood cells is a robust predictor of postdischarge mortality and unplanned hospital readmission. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13054-017-1724-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5479031
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54790312017-06-23 Nucleated red blood cells, critical illness survivors and postdischarge outcomes: a cohort study Purtle, Steven W. Horkan, Clare M. Moromizato, Takuhiro Gibbons, Fiona K. Christopher, Kenneth B. Crit Care Research BACKGROUND: Little is known about risk factors associated with out-of-hospital outcomes in survivors of critical illness. We hypothesized that the presence of nucleated red blood cells in patients who survived critical care would be associated with adverse outcomes following hospital discharge. METHODS: We performed a two-center observational cohort study of patients treated in medical and surgical intensive care units in Boston, Massachusetts. All data were obtained from the Research Patient Data Registry at Partners HealthCare. We studied 2878 patients, age ≥ 18 years, who received critical care between 2011 and 2015 and survived hospitalization. The exposure of interest was nucleated red blood cells occurring from 2 days prior to 7 days after critical care initiation. The primary outcome was mortality in the 90 days following hospital discharge. Secondary outcome was unplanned 30-day hospital readmission. Adjusted odds ratios were estimated by multivariable logistic regression models with inclusion of covariate terms thought to plausibly interact with both nucleated red blood cells and outcome. Adjustment included age, race (white versus nonwhite), gender, Deyo–Charlson Index, patient type (medical versus surgical), sepsis and acute organ failure. RESULTS: In patients who received critical care and survived hospitalization, the absolute risk of 90-day postdischarge mortality was 5.9%, 11.7%, 15.8% and 21.9% in patients with 0/μl, 1–100/μl, 101–200/μl and more than 200/μl nucleated red blood cells respectively. Nucleated red blood cells were a robust predictor of postdischarge mortality and remained so following multivariable adjustment. The fully adjusted odds of 90-day postdischarge mortality in patients with 1–100/μl, 101–200/μl and more than 200/μl nucleated red blood cells were 1.77 (95% CI, 1.23–2.54), 2.51 (95% CI, 1.36–4.62) and 3.72 (95% CI, 2.16–6.39) respectively, relative to patients without nucleated red blood cells. Further, the presence of nucleated red blood cells is a significant predictor of the odds of unplanned 30-day hospital readmission. CONCLUSION: In critically ill patients who survive hospitalization, the presence of nucleated red blood cells is a robust predictor of postdischarge mortality and unplanned hospital readmission. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13054-017-1724-z) contains supplementary material, which is available to authorized users. BioMed Central 2017-06-21 /pmc/articles/PMC5479031/ /pubmed/28633658 http://dx.doi.org/10.1186/s13054-017-1724-z Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Purtle, Steven W.
Horkan, Clare M.
Moromizato, Takuhiro
Gibbons, Fiona K.
Christopher, Kenneth B.
Nucleated red blood cells, critical illness survivors and postdischarge outcomes: a cohort study
title Nucleated red blood cells, critical illness survivors and postdischarge outcomes: a cohort study
title_full Nucleated red blood cells, critical illness survivors and postdischarge outcomes: a cohort study
title_fullStr Nucleated red blood cells, critical illness survivors and postdischarge outcomes: a cohort study
title_full_unstemmed Nucleated red blood cells, critical illness survivors and postdischarge outcomes: a cohort study
title_short Nucleated red blood cells, critical illness survivors and postdischarge outcomes: a cohort study
title_sort nucleated red blood cells, critical illness survivors and postdischarge outcomes: a cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479031/
https://www.ncbi.nlm.nih.gov/pubmed/28633658
http://dx.doi.org/10.1186/s13054-017-1724-z
work_keys_str_mv AT purtlestevenw nucleatedredbloodcellscriticalillnesssurvivorsandpostdischargeoutcomesacohortstudy
AT horkanclarem nucleatedredbloodcellscriticalillnesssurvivorsandpostdischargeoutcomesacohortstudy
AT moromizatotakuhiro nucleatedredbloodcellscriticalillnesssurvivorsandpostdischargeoutcomesacohortstudy
AT gibbonsfionak nucleatedredbloodcellscriticalillnesssurvivorsandpostdischargeoutcomesacohortstudy
AT christopherkennethb nucleatedredbloodcellscriticalillnesssurvivorsandpostdischargeoutcomesacohortstudy